These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15721298)

  • 1. Resistance to influenza A virus infection by antigen-conjugated CpG oligonucleotides, a novel antigen-specific immunomodulator.
    Hayashi M; Satou E; Ueki R; Yano M; Miyano-Kurosaki N; Fujii M; Takaku H
    Biochem Biophys Res Commun; 2005 Apr; 329(1):230-6. PubMed ID: 15721298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in mice.
    Inoue J; Yotsumoto S; Sakamoto T; Tsuchiya S; Aramaki Y
    J Control Release; 2005 Nov; 108(2-3):294-305. PubMed ID: 16209897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel Ag-specific immunotherapy using CpG oligodeoxynucleotides in a new, unique mouse cutaneous eosinophilic inflammation model.
    Kootiratrakarn T; Fujimura T; Sano K; Okuyama R; Aiba S; Tagami H; Terui T
    Eur J Immunol; 2005 Nov; 35(11):3277-86. PubMed ID: 16245360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigen.
    Baral RN; Saha A; Chatterjee S; Foon KA; Krieg A; Weiner GJ; Bhattacharya-Chatterjee M
    Cancer Immunol Immunother; 2003 May; 52(5):317-27. PubMed ID: 12700947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy-generated tumor cell lysates with CpG-oligodeoxynucleotide enhance immunotherapy efficacy in human papillomavirus 16 (E6/E7) immortalized tumor cells.
    Bae SM; Kim YW; Kwak SY; Kim YW; Ro DY; Shin JC; Park CH; Han SJ; Oh CH; Kim CK; Ahn WS
    Cancer Sci; 2007 May; 98(5):747-52. PubMed ID: 17425690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-administration of CpG oligonucleotides and chenopodium album extract reverse IgG2a/IgG1 ratios and increase IFN-gamma and IL-10 productions in a murine model of asthma.
    Mousavi T; Salek Moghadam A; Falak R; Tebyanian M
    Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):1-6. PubMed ID: 18322305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG-ODN combined with Neospora caninum lysate, but not with excreted-secreted antigen, enhances protection against infection in mice.
    Ribeiro DP; Freitas MM; Cardoso MR; Pajuaba AC; Silva NM; Mineo TW; Silva JS; Mineo JR; Silva DA
    Vaccine; 2009 Apr; 27(19):2570-9. PubMed ID: 19428863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A; Calcaterra C; Mènard S; Balsari A
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Mutwiri G; Benjamin P; Soita H; Babiuk LA
    Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
    Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets.
    Linghua Z; Xingshan T; Fengzhen Z
    Vaccine; 2008 Jan; 26(2):224-33. PubMed ID: 18063448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligodeoxynucleotides containing synthetic immunostimulatory motifs augment potent Th1 immune responses to HBsAg in mice.
    Li Y; Kandimalla ER; Yu D; Agrawal S
    Int Immunopharmacol; 2005 Jun; 5(6):981-91. PubMed ID: 15829414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor therapy with bacterial DNA and toxin: complete regression of established tumor induced by liposomal CpG oligodeoxynucleotides plus interleukin-13 cytotoxin.
    Ishii KJ; Kawakami K; Gursel I; Conover J; Joshi BH; Klinman DM; Puri RK
    Clin Cancer Res; 2003 Dec; 9(17):6516-22. PubMed ID: 14695156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction.
    Bleich A; Janus LM; Smoczek A; Westendorf AM; Strauch U; Mähler M; Hedrich HJ; Fichtner-Feigl S; Schölmerich J; Falk W; Hofmann C; Obermeier F
    Gastroenterology; 2009 Jan; 136(1):278-87. PubMed ID: 18952084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG-ODN inhibits airway inflammation at effector phase through down-regulation of antigen-specific Th2-cell migration into lung.
    Ashino S; Wakita D; Zhang Y; Chamoto K; Kitamura H; Nishimura T
    Int Immunol; 2008 Feb; 20(2):259-66. PubMed ID: 18156622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local therapy with CpG motifs in a murine model of allergic airway inflammation in IFN-beta knock-out mice.
    Matheu V; Treschow A; Teige I; Navikas V; Issazadeh-Navikas S
    Respir Res; 2005 Mar; 6(1):25. PubMed ID: 15748290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J; Adamsson J; Harandi AM
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG oligodeoxinucleotides functions as an effective adjuvant in aged BALB/c mice.
    Maletto BA; Rópolo AS; Liscovsky MV; Alignani DO; Glocker M; Pistoresi-Palencia MC
    Clin Immunol; 2005 Dec; 117(3):251-61. PubMed ID: 16182607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.
    de Jong S; Chikh G; Sekirov L; Raney S; Semple S; Klimuk S; Yuan N; Hope M; Cullis P; Tam Y
    Cancer Immunol Immunother; 2007 Aug; 56(8):1251-64. PubMed ID: 17242927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.